Compare MATW & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MATW | SGP |
|---|---|---|
| Founded | 1850 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 932.9M |
| IPO Year | 1995 | N/A |
| Metric | MATW | SGP |
|---|---|---|
| Price | $25.33 | $23.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | ★ 174.1K | 107.0K |
| Earning Date | 04-29-2026 | 03-26-2026 |
| Dividend Yield | ★ 4.05% | N/A |
| EPS Growth | ★ 59.07 | N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $1,795,737,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.50 | $21.29 |
| 52 Week High | $29.11 | $30.56 |
| Indicator | MATW | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 36.49 |
| Support Level | $23.70 | N/A |
| Resistance Level | $26.04 | $29.83 |
| Average True Range (ATR) | 0.73 | 1.82 |
| MACD | 0.09 | -0.39 |
| Stochastic Oscillator | 71.30 | 23.16 |
Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.